XAD-4 resin hemoperfusion for digitoxic patients with renal failure.
D058186:Acute Kidney Injury / Q000097:blood / Q000628:therapy; D000328:Adult; D000368:Aged; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D003920:Diabetes Mellitus / Q000097:blood / Q000628:therapy; D004077:Digoxin / Q000009:adverse effects* / Q000097:blood / Q000652:urine; D005260:Female; D006207:Half-Life; D006464:Hemoperfusion; D006801:Humans; D007022:Hypotension / Q000209:etiology; D007676:Kidney Failure, Chronic / Q000097:blood / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011137:Polystyrenes / Q000008:administration & dosage*; D011145:Polyvinyls / Q000008:administration & dosage*; D006435:Renal Dialysis / Q000009:adverse effects
D011137:Polystyrenes; D011145:Polyvinyls; C012101:XAD-4 resin; D004077:Digoxin